Insider · CIK 0001136466
Bob G Gower
Files at ENSC (Ensysce Biosciences, Inc.). First filing Feb 1, 2023, latest Aug 18, 2026.
In brief
Bob G Gower files SEC Form 4 as director at ENSC (Ensysce Biosciences, Inc.). Since Feb 1, 2023, Bob G Gower has reported 4 open-market buys worth $1.2M and 0 open-market sells worth $0, the latest filed on Aug 18, 2026.
A track record needs three past buys with six months of prices behind them; Bob G Gower has 0, so none is measured yet.
The newest scored trade: bought $444k of ENSC on Apr 23, 2026, filed Aug 18, 2026, scored 42 (moderate). In the last 12 months: 1 buy worth $444k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ENSC: Ensysce Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | ENSCbuy Ensysce Biosciences, Inc. | $444k 908,614 shares | first purchase | - | |
| 37Weak | ENSCbuy Ensysce Biosciences, Inc. | $44k 90,287 shares | +8% | +10% from low-98% from high | |
| 60Notable | ENSCbuy Ensysce Biosciences, Inc. | $182k 379,300 shares | +50% | +2% from low-98% from high | |
| 51Moderate | ENSCbuy Ensysce Biosciences, Inc. | $500k 357,143 shares | +90% | +21% from low-99% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | ENSC Ensysce Biosciences, Inc. | POpen-market purchase Common Stock | +508,614 | $0.48 | $246k | 516,740 | Aug 18, 2026 |
| Aug 7, 2026 | ENSC Ensysce Biosciences, Inc. | POpen-market purchase Common Stock | +400,000 | $0.50 | $198k | 916,740 | Aug 18, 2026 |
| Apr 23, 2026 | ENSC Ensysce Biosciences, Inc. | CConversion Warrantderivative | +254,307 | - | - | 289,836 | Aug 18, 2026 |
| Mar 2, 2023 | ENSC Ensysce Biosciences, Inc. | POpen-market purchase Common Stock | +90,287 | $0.49 | $44k | 1,222,682 | Mar 6, 2023 |
| Feb 28, 2023 | ENSC Ensysce Biosciences, Inc. | POpen-market purchase Common Stock | +109,300 | $0.49 | $53k | 862,395 | Mar 2, 2023 |
| Mar 1, 2023 | ENSC Ensysce Biosciences, Inc. | POpen-market purchase Common Stock | +270,000 | $0.48 | $129k | 1,132,395 | Mar 2, 2023 |
| Dec 9, 2022 | ENSC Ensysce Biosciences, Inc. | POpen-market purchase Common Stock | +357,143 | $1.40 | $500k | 753,095 | Feb 1, 2023 |
| Dec 9, 2022 | ENSC Ensysce Biosciences, Inc. | AGrant or award Warrantsderivative | +714,286 | - | - | 716,365 | Feb 1, 2023 |
Questions about Bob G Gower
Answered from the filings on this page, as of the latest one.
Is Bob G Gower buying or selling?
In the last 12 months Bob G Gower reported 1 open-market buy worth $444k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $444k of ENSC on Apr 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Bob G Gower's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bob G Gower has 0.
Where does Bob G Gower file Form 4?
Bob G Gower has filed Form 4 at ENSC (Ensysce Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.